Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002871 (
anemia
)
52,094
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Polycomb group (PcG) proteins participate in DNA-binding complexes with gene-repressing activity, many of which have been highlighted for their involvement in hematopoiesis. We have identified a putative PcG protein, termed
MBT-1
, that is associated with Rnf2, an in vivo interactor of PcG proteins.
MBT-1
structurally resembles the H-L(3)MBT protein, whose deletion is predicted to be responsible for myeloid hematopoietic malignancies. The human
MBT-1
gene is located on chromosome 6q23, a region frequently deleted in leukemia cells, and shows a transient expression spike in response to maturation-inducing stimuli in myeloid leukemia cells.
MBT-1
(-/-) myeloid progenitor cells exhibit a maturational deficiency but maintain normal proliferative activities. This results in the accumulation of immature myeloid progenitors and hence, a marked decrease of mature myeloid blood cells, causing the
MBT-1
(-/-) mice to die of
anemia
during a late embryonic stage. Together, we conclude that
MBT-1
specifically regulates the maturational advancement of myeloid progenitor cells during transitions between two developmental stages. We also show that
MBT-1
appears to influence myelopoiesis by transiently enhancing p57(KIP2) expression levels.
...
PMID:Impaired maturation of myeloid progenitors in mice lacking novel Polycomb group protein MBT-1. 1588 54